Latest return on equity
Immunovant Return on equity
Direct answer
Immunovant's return on equity is -80.1%.
The verified market snapshot reports -80.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Immunovant email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -80.1%